Download Free Sample Report

Automated Implantable Cardioverter Defibrillator Market, Global Outlook and Forecast 2022-2028

Automated Implantable Cardioverter Defibrillator Market, Global Outlook and Forecast 2022-2028

  • Published on : 25 May 2022
  • Pages :70
  • Report Code:SMR-7109218

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Automated implantable cardioverter-defibrillator is a device implantable inside the body, able to perform cardioversion, defibrillation, and pacing of the heart. The device is therefore capable of correcting most life-threatening cardiac arrhythmias.
This report contains market size and forecasts of Automated Implantable Cardioverter Defibrillator in global, including the following market information:

  • Global Automated Implantable Cardioverter Defibrillator Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global Automated Implantable Cardioverter Defibrillator Market Sales, 2017-2022, 2023-2028, (K Units)
  • Global top five Automated Implantable Cardioverter Defibrillator companies in 2021 (%)

The global Automated Implantable Cardioverter Defibrillator market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

  • The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
  • Subcutaneous Implantable Cardioverter-Defibrillators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
  • The global key manufacturers of Automated Implantable Cardioverter Defibrillator include Medtronic, Abbott, Boston Scientific, ZOLL Medical, Nihon Kohden, LivaNova PLC, Imricor Medical Systems, MicroPort and St. Jude Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
  • We surveyed the Automated Implantable Cardioverter Defibrillator manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Automated Implantable Cardioverter Defibrillator Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Implantable Cardioverter Defibrillator Market Segment Percentages, by Type, 2021 (%)

  • Subcutaneous Implantable Cardioverter-Defibrillators
  • Transvenous Implantable CardioverterDefibrillator
  • Other

Global Automated Implantable Cardioverter Defibrillator Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Implantable Cardioverter Defibrillator Market Segment Percentages, by Application, 2021 (%)

  • Hospital
  • Specialist Clinic
  • Other

Global Automated Implantable Cardioverter Defibrillator Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Implantable Cardioverter Defibrillator Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Automated Implantable Cardioverter Defibrillator revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Automated Implantable Cardioverter Defibrillator revenues share in global market, 2021 (%)
  • Key companies Automated Implantable Cardioverter Defibrillator sales in global market, 2017-2022 (Estimated), (K Units)
  • Key companies Automated Implantable Cardioverter Defibrillator sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Medtronic
  • Abbott
  • Boston Scientific
  • ZOLL Medical
  • Nihon Kohden
  • LivaNova PLC
  • Imricor Medical Systems
  • MicroPort
  • St. Jude Medical
  • Biotronik
  • Sorin Group
  • Defibtech